The CJC-1295 (No DAC) + Ipamorelin combination is widely studied in laboratory settings for its potential synergistic activity on growth hormone release and receptor signaling. CJC-1295 (No DAC) is a synthetic analog of GHRH with a shorter half-life, while Ipamorelin is a selective ghrelin receptor agonist. Together, they are used in research to investigate growth hormone regulation, peptide signaling, and metabolic pathways under controlled experimental conditions.

Key Details

• Form: Lyophilized powders

• Purity: ≥99% (HPLC verified for each peptide)